Clinical trials recruiting in Wetzlar, Germany
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 1Phase 3 1Not applicable 6
Conditions recruiting in Wetzlar, Germany
Recruiting trials in Wetzlar, Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
- PROCARE - PROstate Cancer Real World Evidence Registry
- Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
- Praegnant Breast Cancer: Early/Advanced/Metastatic
- Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
Common questions
How many clinical trials are recruiting in Wetzlar, Germany?
9 recruiting trials have at least one study site in Wetzlar, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.